Key result
Trim14 knockout macrophages limit Mycobacterium tuberculosis replication vs controls by hyperinducing antimicrobial genes.
Why the study?
The contribution of TRIM proteins to innate immune signaling and gene expression during bacterial infection remains largely unknown.
TRIM14 acts as a critical negative regulator of the type I IFN response in macrophages, and its absence improves the ability to limit M. tuberculosis replication.
TRIM14 may be a host-directed therapy target in TB; hypothesis-generating and should not yet change practice.
Tripartite motif-containing proteins (TRIMs) play a variety of recently described roles in innate immunity. Although many TRIMs regulate type I IFN expression following cytosolic nucleic acid sensing of viruses, their contribution to innate immune signaling and gene expression during bacterial infection remains largely unknown. Because Mycobacterium tuberculosis is an activator of cGAS-dependent cytosolic DNA sensing, we set out to investigate a role for TRIM proteins in regulating macrophage responses to M. tuberculosis. In this study, we demonstrate that TRIM14, a noncanonical TRIM that lacks an E3 ubiquitin ligase RING domain, is a critical negative regulator of the type I IFN response in Mus musculus macrophages. We show that TRIM14 interacts with both cGAS and TBK1 and that macrophages lacking TRIM14 dramatically hyperinduce IFN stimulated gene (ISG) expression following M. tuberculosis infection, cytosolic nucleic acid transfection, and IFN-β treatment. Consistent with a defect in resolution of the type I IFN response, Trim14 knockout macrophages have more phospho-Ser754 STAT3 relative to phospho-Ser727 and fail to upregulate the STAT3 target Socs3, which is required to turn off IFNAR signaling. These data support a model whereby TRIM14 acts as a scaffold between TBK1 and STAT3 to promote phosphorylation of STAT3 at Ser727 and resolve ISG expression. Remarkably, Trim14 knockout macrophages hyperinduce expression of antimicrobial genes like Nos2 and are significantly better than control cells at limiting M. tuberculosis replication. Collectively, these data reveal an unappreciated role for TRIM14 in resolving type I IFN responses and controlling M. tuberculosis infection.
No takes yet. Share an insight, caveat, or question.
Hoffpauir et al. (2020) studied Mycobacterium tuberculosis infection. Trim14 knockout vs. Control cells was evaluated on Type I IFN response and M. tuberculosis replication. Trim14 knockout macrophages hyperinduce expression of antimicrobial genes and are significantly better than control cells at limiting Mycobacterium tuberculosis replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: